Beam, Inc. (BEAM) Tops Q2 EPS by 34c, beats revenue

Beam, Inc. (NASDAQ: BEAM) reported Q2 EPS of ($1.08), $0.34 better than the analyst estimate of ($1.42). Revenue for the quarter came in at $20.12 million versus the consensus estimate of $17.32 million.

For earnings history and earnings-related data on Beam, Inc. (BEAM) click here.

You May Also Be Interested In

• Beam Therapeutics Announces Clearance of Investigational New Drug Application for BEAM-304 for the Treatment of Phenylketonuria (PKU) by the United States (U.S.) Food and Drug Administration
• Pfizer reafffirms 2026 guidance after CFO transition announcement
• JPMorgan Upgrades Sika AG (SIKA:SW) (SKFOF) to Neutral